McMurray, PA – May 2023 – Marking a continued expansion into Pennsylvania, OCLI Vision and Spectrum Vision Partners are thrilled to announce the acquisition of Crossroads Eye Care Associates to continue to build the AIO|OCLI Vision presence in Pittsburgh. Crossroads Eye Care Associates is dedicated to helping their patients achieve the best ocular health through the diagnosis and treatment of various eye conditions and cataract, glaucoma, retina, and eyelid surgeries. With the acquisition of Crossroads, Spectrum Vision Partners now operates 15 eye care clinics and two surgery centers in the state.
OCLI Vision is a leading ophthalmology practice whose growth is supported by the management and administrative services of Spectrum Vision Partners (SVP), an organization serving many of the top ophthalmologists, optometrists and ambulatory eye surgery centers in New York, New Jersey, Connecticut, Pennsylvania, and West Virginia. Crossroads Eye Care Associates is Spectrum’s 9th acquired location so far this year.
“It is with great excitement that I welcome the team from Crossroads Eye Care Associates to the OCLI Vision team! We love expanding our team of talented eye care providers,” noted Tom Burke, SVP’s CEO. “With the addition of Dr. Thomas D’Orazio, an experienced ophthalmologist, and Dr. Rebecca Knorr-Peters, a comprehensive optometrist, we’re able to provide more communities in PA access to top-tier, innovative eye care services. With each new acquisition, we enhance our ability to meet our patients’ unique needs.”
“We are thrilled to welcome Drs. D’Orazio and Knorr-Peters to our practice,” states Lisa Cibik, MD, AIO|OCLI Vision’s Laser Cataract Surgeon and Comprehensive Ophthalmologist. “And look forward to collaborating together on the eye care of more patients in the region”.
The Crossroads office is located at 4160 Washington Rd., McMurray, PA. Dr. Thomas J. D’Orazio has been serving the community for over a decade, specializing in comprehensive ophthalmic care including advanced cataract surgery, glaucoma treatment and management, diabetic eye care and macular degeneration management and cosmetic Botox.
“I couldn’t be more excited to be joining the prestigious OCLI Vision team. The team is renowned for their innovations and comprehensive approach to care. We’re looking forward to stronger partnership with our esteemed colleagues and providing even better care to our patients.” noted Dr. D’Orazio.
For questions or further information regarding the OCLI Vision team or Spectrum Vision Partners, please contact:
Tom Burke
Chief Executive Officer
Greg Wappett
Chief Development Officer
About OCLI Vision
Founded in 1997, OCLI Vision (www.ocli.net) is one of the leading ophthalmology practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.
About Spectrum Vision Partners
Spectrum Vision Partners (SVP) (www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With over 1,400 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports over 50 clinic locations, five state-licensed ambulatory surgery centers, and over 150 surgeons, doctors and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.
About Blue Sea Capital
Blue Sea Capital (www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that invests in growth-oriented lower middle market companies with EBITDA of up to $30 million. The firm has over $1.3 billion in committed capital and invests across three industry verticals: aerospace & defense, healthcare and industrial growth. Blue Sea Capital’s strategy is to partner with talented leaders and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration, industry outperformance and business transformation.